T. Dellit

Critical Care and Intensive Care Medicine · 2007–2016

A researcher in the Science corpus: 3 papers; trusts 7 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom T. Dellit trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Cosgrove
  2. Jonathan R. Nebeker
  3. Matthew E. Falagas
  4. Robert L. Wears
  5. J. Burke
  6. Yehuda Carmeli
  7. C. MacDougall
  8. 古谷 良輔
  9. John F. Hurdle

Who trusts T. Dellit overall

  1. L. Pollack
  2. A. Srinivasan
  3. S. Cosgrove
  4. Neil O. Fishman

Papers from T. Dellit's perspective

Ordered by how strongly the researchers T. Dellit trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
  2. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
  3. The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
  4. Interventions to improve antibiotic prescribing practices for hospital inpatients. (Cochrane Database of Systematic Reviews)
  5. Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
  6. Segmented regression analysis of interrupted time series studies in medication use research (Journal of Clinical Pharmacy and Therapeutics)
  7. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study. (Journal of Allergy and Clinical Immunology)
  8. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. (Archives of Internal Medicine)
  9. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. (The Lancet)
  10. An intervention to decrease catheter-related bloodstream infections in the ICU. (New England Journal of Medicine)

Their papers